Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion

Dongli Linghu(Nanfang Hospital), Linlin Sun(Tianjin Medical University General Hospital)
Journal for ImmunoTherapy of Cancer
July 1, 2025
Cited by 7


Related Papers